RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 21228
Ticker: RXRX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-04-16
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: RXRX

Detail

Enriched 2026-08-14 20:47

Market cap: $1,764,331,876.23
Shares outstanding (class): 535,342,170
Shares outstanding (weighted): 536,271,087
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 600
Location: SALT LAKE CITY, UT
Homepage: https://www.recursion.com
Description: Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Market cap and share counts drift.

Funds holding this security

89 funds · 90 positions · $262.90M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$51.37M	0.69%	16,732,511 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$47.86M	0.00%	15,588,107 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$35.09M	0.02%	11,428,720 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$34.27M	0.05%	11,162,407 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$19.63M	0.05%	6,393,404 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$17.70M	0.02%	5,764,055 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$11.49M	0.09%	3,744,214 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$10.50M	0.13%	3,419,857 NS	FIGI
First Trust Nasdaq Artificial Intelligence and … First Trust Exchange-Traded Fund VI	ROBT	$8.01M	1.31%	2,610,067 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$2.29M	0.05%	744,909 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$2.16M	0.00%	702,796 NS	FIGI
American Beacon ARK Transformational Innovation… AMERICAN BEACON FUNDS	—	$1.87M	1.19%	608,953 NS	FIGI
State Street(R) SPDR(R) S&P Kensho New Economie… SPDR SERIES TRUST	KOMP	$1.52M	0.06%	496,106 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$1.46M	0.04%	475,367 NS	FIGI
Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust	—	$1.07M	0.09%	348,416 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERRXRX
FIGI_COMPOSITEBBG00PQ4XJ45
FIGI_SHARE_CLASSBBG00PQ4XJ54
CIK0001601830
ISINUS75629V1044
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Recursion Pharmaceuticals is a clinical-stage biotech company developing drugs using AI, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.